From holistically handholding one of the first recombinant vaccines to be developed and introduced in India to steering the development of the first transgenic food crop in the country we have been partners in success for biotechnology initiatives and enterprises in the country. We have had the privilege of advising policymakers and playing a role in shaping critical initi atives to foster translational innovation engagement and growth of the sector.
Indian companies have succeeded in emerging as reliable suppliers of human vaccines to global markets and are now making a strong foray into biosimilars. Several traditional chemistry driven pharmaceutical companies are now at the crossroads of this transition from small molecule generics to biosimilars in their quest for continued global leadership. There is also nascent engagement in novel biologics and the growing domestic market has triggered significant interest in veterinary vaccines and biologics as well. Biologic agricultural inputs are a growing opportunity and we are engaged with traditional chemical fertilizer companies riding the biologics wave and striving to establish themselves. We have also been deeply engaged with seed companies building their pipeline of agri-biotechnology driven products including transgenic seeds and adopting novel breeding practices such as marker assisted breeding.
We take pride in our comprehensive understanding of markets as well as product development considerations such as technology access, regulatory requirements, clinical validation pathway and intellectual property implications. Talk to us about how we can help you establish or grow in your biotechnology endeavors.